Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

SHEZF · OTC
Analyze with AI
Key StatsIncome StatementBalance SheetCash Flow
AnnualQuarterly
KMB
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets––––
Cash & Equivalents$1,689$1,852$2,139$2,944
Short-Term Investments$868$414$1,312$981
Receivables$1,278$1,275$1,626$1,543
Inventory$5,394$6,654$6,844$4,708
Other Curr. Assets$392$409$469$593
Total Curr. Assets$9,621$10,604$12,390$10,770
Property Plant & Equip (Net)$2,648$2,634$2,477$2,537
Goodwill$2,357$2,322$2,351$2,152
Intangibles$406$493$572$587
Long-Term Investments$955$2,100$1,152$1,637
Tax Assets$283$321$140$122
Other NC Assets$1,074$729$1,733$1,304
Total NC Assets$7,722$8,600$8,425$8,339
Other Assets$0$0$0$0
Total Assets$17,344$19,203$20,814$19,108
Liabilities––––
Payables$300$302$427$386
Short-Term Debt$1,839$1,881$4,056$1,886
Tax Payable$154$196$142$159
Deferred Revenue$0$0$434$1,102
Other Curr. Liab.$1,407$2,607$516$1,259
Total Curr. Liab.$3,699$4,986$5,576$4,791
LT Debt$1,139$1,900$2,407$2,354
Deferred Rev, NC$27$0$33$17
Deferred Tax Liab, NC$242$0$329$275
Other NC Liab.$34$328$62$147
Total NC Liab.$1,442$2,229$2,831$2,793
Other Liabilities$0$0$0$0
Cap. Leases$58$90$111$104
Total Liabilities$5,141$7,215$8,407$7,585
Equity––––
Pref Stock$0$0$0$0
Common Stock$1,467$1,467$1,467$1,467
Retained Earnings$4,588$3,386$4,314$4,184
AOCI-$1,436$158$0-$183
Other Equity$7,529$6,901$6,531$5,944
Total Equity$12,149$11,913$12,311$11,411
Supplemental Information––––
Minority Interest$53$75$97$112
Total Liab. & Tot. Equity$17,344$19,203$20,814$19,108
Net Debt$1,289$1,930$4,325$1,296
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) Financial Statements & Key Stats | AlphaPilot